Sunshine Biopharma Inc. Quarterly Operating Lease, Liability, Noncurrent in USD from Q4 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Sunshine Biopharma Inc. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q4 2018 to Q4 2024.
  • Sunshine Biopharma Inc. Operating Lease, Liability, Noncurrent for the quarter ending December 31, 2024 was $745K, a 38.2% increase year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $745K +$206K +38.2% Dec 31, 2024 10-K 2025-04-01
Q3 2024 $440K -$115K -20.8% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $463K -$134K -22.4% Jun 30, 2024 10-Q/A 2024-08-20
Q1 2024 $497K -$116K -18.9% Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $539K -$103K -16.1% Dec 31, 2023 10-K 2025-04-01
Q3 2023 $556K Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $597K Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $613K Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $642K +$642K Dec 31, 2022 10-K 2024-03-28
Q4 2021 $0 Dec 31, 2021 10-K 2023-04-04
Q1 2019 $49.1K Mar 31, 2019 10-Q 2019-05-20
Q4 2018 $0 Dec 31, 2018 10-Q 2019-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.